A bipartisan group of senators has reached a deal to cap the price of insulin at $35, marking a potential breakthrough after years of negotiations over reducing costs for Americans living with diabetes.[#item_full_content]
Ocse, Pil italiano rivisto a +0,5%: “Da energia shock sui prezzi. Contro rincari misure mirate”
Read More [#item_full_content]